← Every company

Inovio Pharmaceuticals Inc SEC Filings

What Inovio Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

INO overview →
Filings on file
110
since Oct 14, 2016
Warning signs
1
latest Nov 2, 2023
Last results
Aug 12, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
May 28, 2024
Executive or director changeShareholder vote
8-K
Read ↗
May 18, 2023
Executive or director changeShareholder vote
8-K
Read ↗
May 17, 2022
Executive or director changeShareholder vote
8-K
Read ↗
May 10, 2022
Executive or director changeResults announced
8-K
Read ↗
May 17, 2021
Executive or director changeShareholder vote
8-K
Read ↗
Sep 3, 2020
Executive or director change
8-K
Read ↗
Jan 15, 2020
Executive or director change
8-K
Read ↗
May 10, 2019
Executive or director changeShareholder vote
8-K
Read ↗
Mar 25, 2019
Executive or director change
8-K
Read ↗
Mar 12, 2019
Executive or director change
8-K
Read ↗
Feb 26, 2019
Executive or director change
8-K
Read ↗
Jan 3, 2019
Executive or director change
8-K
Read ↗
Dec 6, 2017
Executive or director change
8-K
Read ↗
May 16, 2017
Executive or director changeShareholder vote
8-K
Read ↗
Mar 24, 2017
Executive or director change
8-K
Read ↗
Mar 9, 2017
Executive or director change
8-K
Read ↗

Source: Inovio Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on INO

Related datasets